Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMUX compared with PRQR: revenue, margins and what each company keeps, and the suppliers and customers both name
IMUX
Immunic, Inc.
Change
Mkt cap
Revenue
Revenue
PRQR
ProQR Therapeutics N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMUX
Immunic, Inc.
vs
PRQR
ProQR Therapeutics N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IMUX, solid
PRQR, dashed
Supply-chain overlap
Revenue flow
IMUX: latest quarter not drawable. PRQR: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IMUX
7
—
Daiichi Sankyo
unlisted
supplier
—
4SC
unlisted
supplier
—
Fraunhofer Institute
unlisted
supplier
—
German Federal Ministry of Finance
unlisted
supplier
3 more · IMUX chain
›
Shared
0
No shared counterparties.
Only PRQR
1
LLY
Eli Lilly
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
IMUX
Immunic, Inc.
Change
7.53
▼
−3.42%
· post 7.53
Mkt cap
$102.5M
PRQR
ProQR Therapeutics N.V.
Change
1.38
▼
−4.31%
· post 1.43
Closed
Oct 30 '26
Mkt cap
$146.5M
vs
Compare
Closed
Oct 30 '26
IMUX
Immunic, Inc.
vs
PRQR
ProQR Therapeutics N.V.
7.53
▼
−3.42%
post 7.53
Price
1.38
▼
−4.31%
post 1.43
$102.5M
Mkt cap
$146.5M
Change
Change
IMUX
7.53
▼
−3.42%
vs
PRQR
1.38
▼
−4.31%
Closed
Oct 30 '26